# Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients

> **NCT00663455** · PHASE4 · TERMINATED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 50 (actual)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** Reduction of cyclosporine A (CSA)-dosing

## Key facts

- **NCT ID:** NCT00663455
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2012-12
- **Final completion:** 2013-06
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Recruitment goals were not achieved. Extension of the trial concept had to be abjected due to methodological reasons.
- **Last updated:** 2015-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663455, "Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00663455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*